{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T21:48:11Z","timestamp":1759960091437},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1996,3,1]],"date-time":"1996-03-01T00:00:00Z","timestamp":825638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jap J Human Genet"],"published-print":{"date-parts":[[1996,3]]},"DOI":"10.1007\/bf01892624","type":"journal-article","created":{"date-parts":[[2005,7,5]],"date-time":"2005-07-05T12:37:44Z","timestamp":1120567064000},"page":"167-175","source":"Crossref","is-referenced-by-count":8,"title":["Incidence of peroxisomal disorders in Japan"],"prefix":"10.1038","volume":"41","author":[{"given":"Yasuyuki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Shimozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigehiro","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Orii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01892624_CR1","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/0387-7604(94)90007-8","volume":"16","author":"J Asano","year":"1994","unstructured":"Asano J, Suzuki Y, Yajima S, Inoue K, Shimozawa I, Kondo N, Murase M, Orii T (1994): Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy. Brain Dev16: 454\u2013458","journal-title":"Brain Dev"},{"key":"BF01892624_CR2","first-page":"344","volume":"151","author":"FR Brown","year":"1982","unstructured":"Brown FR, McAdams AJ, Cummins JW, Konkol R, Singh I, Moser AB, Moser HW (1982): Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J151: 344\u2013361","journal-title":"Johns Hopkins Med J"},{"key":"BF01892624_CR3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.182.4107.62","volume":"182","author":"S Goldfischer","year":"1973","unstructured":"Goldfischer S, Moore CL, Johnson AB, Spiro AJ, Valsamis MP, Wisniewski HK, Ritch RH, Norton WT, Rapin I, Gartner LM (1973): Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science182: 62\u201364","journal-title":"Science"},{"key":"BF01892624_CR4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1471-4159.1976.tb04462.x","volume":"26","author":"M Igarashi","year":"1976","unstructured":"Igarashi M, Schaumburg HH, Powers J, Kishimoto Y, Kolodney E, Suzuki K (1976): Fatty acid abnormality in adrenoleukodystrophy. J Neurochem26: 851\u2013860","journal-title":"J Neurochem"},{"key":"BF01892624_CR5","first-page":"2287","volume-title":"The metabolic and molecular bases of inherited disease","author":"PB Lazarow","year":"1995","unstructured":"Lazarow PB, Moser HW (1995): Disorders, of peroxisome biogenesis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2287\u20132324"},{"key":"BF01892624_CR6","first-page":"196","volume":"9","author":"HW Moser","year":"1994","unstructured":"Moser HW, Kok F, Neumann S, Borel J, Bergin A, Mostafa SD, Panosha R, Davoli CT, Shankroff J, Smith KD (1994): Adrenoleukodystrophy update: genetics and effect of Lorenzo's oil therapy in asymptomatic patients. Int Pediatr9: 196\u2013204","journal-title":"Int Pediatr"},{"key":"BF01892624_CR7","first-page":"2325","volume-title":"The metabolic and molecular bases of inherited disease","author":"HW Moser","year":"1995","unstructured":"Moser HW, Smith KD, Moser AB (1995): X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2325\u20132349"},{"key":"BF01892624_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0006-291X(84)91430-X","volume":"120","author":"RBH Schutgens","year":"1984","unstructured":"Schutgens RBH, Romeyn GJ, Wanders RJA, van den Bosch H, Schrakamp G, Heymans HSA (1984): Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hapato-renal) syndrome. Biochem Biophys Res Commun120: 179\u2013184","journal-title":"Biochem Biophys Res Commun"},{"key":"BF01892624_CR9","first-page":"843","volume":"52","author":"N Shimozawa","year":"1993","unstructured":"Shimozawa N, Suzuki Y, Orii T, Moser A, Moser H, Wanders RJA (1993a): Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect. Am J Hum Genet52: 843\u2013844","journal-title":"Am J Hum Genet"},{"key":"BF01892624_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/pd.1970130212","volume":"13","author":"N Shimozawa","year":"1993","unstructured":"Shimozawa N, Suzuki Y, Orii T, Tsukamoto T, Fujiki Y (1993b): Prenatal diagnosis of Zellweger syndrome using DNA analysis. Prenatal Diagn13: 149","journal-title":"Prenatal Diagn"},{"key":"BF01892624_CR11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0009-8981(86)90152-X","volume":"156","author":"Y Suzuki","year":"1986","unstructured":"Suzuki Y, Orii T, Mori M, Tatibana M, Hashimoto T (1986): Deficient activities and proteins of peroxisomal \u03b2-oxidation enzymes in infants with Zellweger syndrome. Clin Chim Acta156: 191\u2013196","journal-title":"Clin Chim Acta"},{"key":"BF01892624_CR12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0022-3476(88)80011-8","volume":"113","author":"Y Suzuki","year":"1988","unstructured":"Suzuki Y, Shimozawa N, Orii T, Igarashi N, Kono N, Matsui A, Inoue Y, Yokota S, Hashimoto T (1988): Zellweger-like syndrome with detectable hepatic peroxisomes: a variant form of peroxisomal disorder. J Pediatr113: 841\u2013845","journal-title":"J Pediatr"},{"key":"BF01892624_CR13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1247\/csf.15.301","volume":"15","author":"Y Suzuki","year":"1990","unstructured":"Suzuki Y, Yamaguchi S, Orii T, Tsuneoka M, Tashiro Y (1990): Nonspecific lipid transfer protein (sterol carrier protein-2) defective in patients with deficient peroxisomes. Cell Struct Funct15: 301\u2013308","journal-title":"Cell Struct Funct"},{"key":"BF01892624_CR14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0006-2952(91)90544-F","volume":"41","author":"Y Suzuki","year":"1991","unstructured":"Suzuki Y, Shimozawa N, Yajima S, Yamaguchi S, Orii T, Hashimoto T (1991): Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseases. Biochem Pharmacol41: 453\u2013456","journal-title":"Biochem Pharmacol"},{"key":"BF01892624_CR15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajmg.1320540108","volume":"54","author":"Y Suzuki","year":"1994","unstructured":"Suzuki Y, Shimozawa N, Yajima S, Tomatsu S, Kondo N, Nakada Y, Akaboshi S, Iai M, Tanabe Y, Hashimoto T, Wanders RJA, Schutgens RBH, Moser HW, Orii T (1994): Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: identification by means of complementation analysis. Am J Hum Genet54: 36\u201343","journal-title":"Am J Hum Genet"},{"key":"BF01892624_CR16","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1471-4159.1981.tb01698.x","volume":"36","author":"S Tsuji","year":"1981","unstructured":"Tsuji S, Suzuki M, Ariga T, Sekine M, Kuriyama M, Miyatake T (1981): Abnormality of long-chain fatty acids in, erythrocyte membrane sphingomyelin from patients with adrenoleukodystrophy. J Neurochem36: 1046\u20131049","journal-title":"J Neurochem"},{"key":"BF01892624_CR17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00219334","volume":"88","author":"S Yajima","year":"1992","unstructured":"Yajima S, Suzuki Y, Shimozawa N, Yamaguchi S, Orii T, Fujiki Y, Osumi T, Hashimoto T, Moser HW (1992): Complementation study of peroxisome-deficient, disorders by immunofluorescence staining and characterization of fused cells. Hum Genet88: 491\u2013499","journal-title":"Hum Genet"}],"container-title":["Japanese Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg19965.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg19965","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/BF01892624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/jhg19965.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T19:30:01Z","timestamp":1638387001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg19965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,3]]}},"alternative-id":["BF01892624"],"URL":"https:\/\/doi.org\/10.1007\/bf01892624","relation":{},"ISSN":["0021-5074"],"issn-type":[{"value":"0021-5074","type":"print"}],"subject":[],"published":{"date-parts":[[1996,3]]}}}